David T. Nash, BS , MD

Eyes
Eyes
04/27/2011
Mikayla Spangler, PharmD; Shailendra K. Saxena, MD, PhD; David T. Nash, BS , MD
<div id="article-content-body"><p><img src="/sites/default/files/old/img_4db8c72408d2e.jpg" width="150" style="margin-left: 8px; margin-right: 8px; float:...
04/27/2011
Eyes
Eyes
04/27/2011
Mikayla Spangler, PharmD; Shailendra K. Saxena, MD, PhD; David T. Nash, BS , MD
<div id="article-content-body"><p><img src="/sites/default/files/old/img_4db8c72408d2e.jpg" width="150" style="margin-left: 8px; margin-right: 8px; float:...
04/27/2011
Eyes
Eyes
04/27/2011
Mikayla Spangler, PharmD; Shailendra K. Saxena, MD, PhD; David T. Nash, BS , MD
<div id="article-content-body"><p><img src="/sites/default/files/old/img_4db8c72408d2e.jpg" width="150" style="margin-left: 8px; margin-right: 8px; float:...
04/27/2011
Lipids
Lipids
04/28/2011
David T. Nash, BS , MD
The prevention of symptomatic coronary heart disease represents a significant health care priority, especially in a population that is growing older and more obese.
04/28/2011
Cardiovascular Risk
Cardiovascular Risk
04/30/2011
David T. Nash, BS , MD
Despite the many double-blind, placebo-controlled trials that have demonstrated the efficacy of statins in reducing the risk of cardiovascular events, a large number of patients who are treated with these...
04/30/2011
Review Article
Review Article
04/30/2011
David T. Nash, BS , MD
Although the cardiovascular death rate has declined in the United States, the number of hospitalizations for cardiac disease has not.
04/30/2011
frailty
frailty
09/17/2013
David T. Nash, BS , MD
By 2025, there will be 1.2 billion frail individuals in the world, 75% of which live in developing nations, according to WHO data. As such, frailty is evolving into a medical care challenge that will...
09/17/2013